Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Develo** a fit-for-purpose composite symptom score as a symptom burden endpoint for clinical trials in patients with malignant pleural mesothelioma

    We developed a composite symptom score (CSS) representing disease-related symptom burden over time in patients with malignant pleural mesothelioma (MPM). Longitudinal data were collected from an open-label Pha...

    Charles S. Cleeland, Karen N. Keating, Brian Cuffel, Cem Elbi in Scientific Reports (2024)

  2. No Access

    Article

    What Defines the Value of Minimally Invasive Surgery for Cancer Patients?

    Yuki Hirata MD, PhD, Heather Lyu MD, MBI in Annals of Surgical Oncology (2024)

  3. Article

    Open Access

    National survey on the availability of oncology palliative care services at tertiary general and cancer hospitals in China

    This nationwide survey studied the level of palliative care (PC) access for Chinese patients with cancer among cancer care providers either in tertiary general hospitals or cancer hospitals in China.

    **aomei Li, **n Shelley Wang, Haili Huang, Miao Liu, Yinan Wu in BMC Palliative Care (2023)

  4. Article

    Open Access

    Trans-pacific multicenter collaborative study of minimally invasive proximal versus total gastrectomy for proximal gastric and gastroesophageal junction cancers

    The current standard operation for proximal gastric and gastroesophageal junction (P/GEJ) cancers with limited esophageal extension is total gastrectomy (TG). TG is associated with impaired appetite and weight...

    Naruhiko Ikoma, Travis Grotz, Hirofumi Kawakubo, Hyoung-Il Kim in BMC Surgery (2023)

  5. No Access

    Article

    ASO Visual Abstract: Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study

    Li Tang MD, Hongfan Yu BSc, Wei Dai MD, **aojun Yang MD in Annals of Surgical Oncology (2023)

  6. No Access

    Article

    Symptom Trajectories Informing Patient Care After Lung Cancer Surgery: A Longitudinal Patient-Reported Outcome Study

    Application of patient-reported outcomes (PROs) in surgical oncology has been limited because of patient heterogeneity. We analyzed symptom trajectories and their associations with recovery outcomes after lung...

    Li Tang MD, Hongfan Yu BSC, Wei Dai MD, **aojun Yang MD in Annals of Surgical Oncology (2023)

  7. Article

    Opioid-sparing anesthesia and patient-reported outcomes after open gynecologic surgery: a historical cohort study

    Dexmedetomidine and ketamine may be administered intraoperatively as continuous infusions to provide opioid-sparing anesthesia. Recent evidence has yielded controversial results regarding the impact of opioid-...

    Andres Zorrilla-Vaca MD, Pedro T. Ramirez MD in Canadian Journal of Anesthesia/Journal can… (2022)

  8. No Access

    Article

    Identifying patients who suffered from post-discharge cough after lung cancer surgery

    To establish a discharge cutoff point (CP) on a simple patient-reported cough score to identify patients requiring post-discharge cough intervention.

    **gyu Zhang, Xueyao Su, Wei Xu, Qingsong Yu, Wei Dai in Supportive Care in Cancer (2022)

  9. No Access

    Article

    Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery

    The aim of this study was to define a threshold of minimal clinically important improvement (MCII) for interpreting patient condition following video-assisted thoracoscopic surgery (VATS).

    Wei Xu MS, Wei Dai MD, Zhen Gao MD, **n Shelley Wang MD, MPH in Annals of Surgical Oncology (2022)

  10. Article

    Correction to: Establishment of Minimal Clinically Important Improvement for Patient-Reported Symptoms to Define Recovery After Video-Assisted Thoracoscopic Surgery

    Wei Xu MS, Wei Dai MD, Zhen Gao MD, **n Shelley Wang MD, MPH in Annals of Surgical Oncology (2022)

  11. No Access

    Article

    Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial

    Patients with multiple myeloma (MM) experience substantial cancer/treatment-related symptom burden during maintenance therapy. This is a phase II randomized, double-blinded, placebo-controlled clinical trial t...

    **n Shelley Wang, Qiuling Shi, Tito R. Mendoza in Supportive Care in Cancer (2021)

  12. Article

    Open Access

    Translation and validation of the Chinese version of the MD Anderson symptom inventory for measuring perioperative symptom burden in patients with gynecologic cancer

    Gynecologic cancers are among the most prevalent malignancies in China. Cervical and uterine cancer respectively account for the sixth and eighth highest incidence of cancer among Chinese women. Abdominal surg...

    Ting Zhang, Ying-ying Zheng, Zhi-rong Yang, Qiuling Shi in BMC Women's Health (2021)

  13. No Access

    Article

    Symptom burden and its functional impact in patients with “symptomatic” relapsed or refractory multiple myeloma

    Relapsed or refractory multiple myeloma (RRMM) is labeled “symptomatic” based on laboratory values, but not relevant to quantitative measure of patient’s perspectives. This study aimed to describe symptom burd...

    Mona Kamal, **n Shelley Wang, Qiuling Shi, Teresa M. Zyczynski in Supportive Care in Cancer (2021)

  14. Article

    Open Access

    The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment

    The validation of the Treatment-induced Neuropathy Assessment Scale (TNAS v2.0), a patient-reported outcome measure of symptoms associated with cancer treatment-induced peripheral neuropathy (TIPN), was previo...

    Tito R. Mendoza, Loretta A. Williams, Qiuling Shi in Journal of Patient-Reported Outcomes (2020)

  15. No Access

    Article

    Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial

    Local/systemic symptoms during cancer therapy may be exacerbated by dysregulated inflammation and its downstream toxic effects. Minocycline can suppress proinflammatory cytokine release; therefore, we investig...

    G. Brandon Gunn, Tito R. Mendoza, Adam S. Garden in Supportive Care in Cancer (2020)

  16. No Access

    Article

    Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection

    Symptom burden, as measured by patient-reported outcome (PRO) metrics, may have prognostic value in various cancer populations, but remains underreported. The aim of this project was to determine the predictiv...

    Heather A. Lillemoe MD, Rebecca K. Marcus MD in Annals of Surgical Oncology (2019)

  17. No Access

    Article

    Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study

    Clinician ratings of concurrent chemoradiation (CRT)-induced radiation pneumonitis (RP) in patients with non-small cell lung cancer (NSCLC) are based on both imaging and patient-reported lung symptoms. We comp...

    **bo Yue, Qiuling Shi, Ting Xu, Melenda Jeter, Ting-Yu Chen in Quality of Life Research (2018)

  18. No Access

    Article

    Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma

    We aimed to determine the utility of a patient-reported outcome (PRO) as it relates to patient performed testing (PPT) for measuring functional status in multiple myeloma patients after autologous hematopoieti...

    Nina Shah, Qiuling Shi, Sergio Giralt, Loretta Williams in Quality of Life Research (2018)

  19. Article

    Open Access

    Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma

    The hepatocyte growth factor/c-MET pathway has been implicated in the pathobiology of multiple myeloma, and c-MET inhibitors induce myeloma cell apoptosis, suggesting that they could be useful clinically. We c...

    Muhamed Baljevic, Shadia Zaman, Veerabhadran Baladandayuthapani in Annals of Hematology (2017)

  20. No Access

    Article

    The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome

    Debilitating fatigue is a core symptom of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS); however, the utility of patient-reported symptom outcome measures of fatigue for ME/CFS patients is probl...

    Kyle W. Murdock, **n Shelley Wang, Qiuling Shi in Quality of Life Research (2017)

previous disabled Page of 2